Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales32 63930 39026 10720 79421 11621 701
EBITDA23 66820 34716 40512 27212 37412 564
Operating profit (EBIT)23 39620 03316 03110 73411 09011 457
Pre-Tax Profit (EBT)------
Net income18 10813 5014 6286 4337 1917 794
P/E ratio8,507,2020,414,413,111,7
EPS ( $ )11,99,943,514,955,436,05
Dividend per Share ( $ )1,291,842,082,272,462,61
Yield1,27%2,57%2,90%3,20%3,46%3,68%
Reference price ( $ )101.1971.6171.6471.0771.0771.07
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt7 573-8 03213 02816 24911 726
Finance-32 380----
Operating income (EBITDA)23 66820 34716 40512 27212 37412 564
Leverage
(Debt/EBITDA)
0,32x-0,49x1,06x1,31x0,93x
Capital Expenditure747748590635651679
Book Value Per Share (BVPS)13,2 $14,6 $15,7 $20,3 $23,1 $25,0 $
Cash Flow per Share12,9 $12,3 $9,02 $7,47 $7,59 $7,73 $
Announcement Date02/02/2016
09:00pm
02/07/2017
09:01pm
02/06/2018
09:01pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 92 410 M$ -
Entreprise Value (EV) 105 437 M$ 108 658 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 14,4x 13,1x
Capitalization / Revenue 4,44x 4,38x
EV / Revenue 5,07x 5,15x
EV / EBITDA 8,59x 8,78x
Yield (DPS / Price) 3,20% 3,46%
Price to book (Price / BVPS) 3,50x 3,07x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 51,6% 52,5%
operating Leverage (Delta EBIT / Delta Sales) -1,62x 2,13x
Net Margin (Net Profit / Revenue) 30,9% 34,1%
ROA (Net Profit / Asset) 10,9% 12,0%
ROE (Net Profit / Equities) 45,5% 56,1%
Rate of Dividend 45,9% 45,2%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   3,06% 3,08%
Cash Flow / Sales 46,7% 46,8%
Capital Intensity (Assets / Sales) 2,83x 2,84x
Financial Leverage (Net Debt / EBITDA) 1,06x 1,31x
EPS & Dividend